简介:AbstractBackground:There have been few real-life dose-comparing studies on the efficacy and safety of secukinumab in Chinese patients with plaque psoriasis. We conducted a real-life cohort study to investigate the efficacy and safety of secukinumab 150 and 300 mg in Chinese patients with moderate-to-severe plaque psoriasis.Methods:A total of 106 patients with moderate-to-severe plaque psoriasis were included in this study. Patients received either secukinumab 150 mg or secukinumab 300 mg according to patients’ weights and severity of psoriasis. The treatment continued for at least 24 weeks. The efficacy was evaluated by improvement in the psoriasis area and severity index (PASI) scores. The safety was also analyzed.Results:Fifty-nine patients (55.7%) were treated with secukinumab 300 mg and 47 patients (44.3%) were treated with secukinumab 150 mg. After 12-week treatment, PASI75/90/100 responses were achieved in 100%, 97.8%, and 95.7% of patients, respectively, in secukinumab 150 mg group, and the efficacy was maintained to week 24. In secukinumab 300 mg group, PASI75/90/100 responses were achieved in 93.2%, 81.4%, and 76.3% of patients, respectively, at week 12. In this group, PASI75/90/100 responses reached 91.5%, 86.4%, and 79.9%, respectively, at week 24. Biologic-experienced patients had lower responses than biologic-naïve patients. Secukinumab 150 and 300 mg were well tolerated. Five patients discontinued treatment due to poor response, adverse event, or economic reasons.Conclusions:This real-life study demonstrated that high PASI 90 and PASI 100 responses were achieved in Chinese psoriasis patients receiving secukinumab 150 or 300 mg. Biologic-naïve was associated with better clinical efficacy.
简介:Inrecentyears,lifecycleassessment(LCA)methodiswidelyusedingreenmanufacturing,energysaving,andemissionreductionofironandsteelproduction.BasedonthecarbonsteelLCAresearchandrelevantstandardsathomeandabroad,theapplicationofLCAinstainlesssteelinBaosteelwasstudied.Throughthestudyofstainlesssteel'sgoalandscope,lifecycleinventory,LCAandinterpretation,knowledgeandexperienceofLCA'sapplicationinstainlesssteelwasobtained.
简介:
简介:Itiswellknownthatsharkskinsurfacecaneffectivelyinhabittheoccurrenceofturbulenceandreducethewallfriction,butinordertounderstandthemechanismofdragreduction,onehastosolvetheproblemoftheturbulentflowongrooved-scalesurface,andinthatrespect,thedirectnumericalsimulationisanimportanttool.Inthisarticle,basedontherealbiologicalsharkskin,themodelofrealsharkskinisbuiltthroughhigh-accuratescanninganddataprocessing.Theturbulentflowonarealsharkskiniscomprehensivelysimulated,andbasedonthesimulation,thedragreductionmechanismisdiscussed.Inaddition,inordertovalidatethedrag-reducingeffectofsharkskinsurface,actualexperimentswerecarriedoutinwatertunnel,andtheexperimentalresultsareapproximatelyconsistentwiththenumericalsimulation.
简介:
简介:Thegeneralconceptofdatacompressionconsistsinremovingtheredundancyexistingindatatofindamorecompactrepresentation.Thispaperisconcernedwithanewmethodofcompressionusingthesecondgenerationwaveletsbasedontheliftingscheme,whichisasimplebutpowerfulwaveletconstructionmethod.Ithasbeenprovedbyitssuccessfulapplicationtoareal-timemonitoringsystemoflargehydraulicmachinesthatitisapromisingcompressionmethod.
简介:ObjectivesToassesstherelationshipbetweenpeakoxygenconsumption(PVO2)andtheambulationdistanceinsix-minutewalktest(6MWT)amongthehealthysubjects.MethodsThe51healthysubjectswererecruitedforthesix-minutewalktest.Dataofpulmonarygasexchangebreathbybreath,suchasVO2,VCO2werereal-timemeasuredwithwirelessremotesensingK4B2,sotostudytherelationshipbetweenpeakoxygenuptakeandtheambulationdistance.ResultsItwasnoticedthattherewasapositivelinearcorrelationbetweentheambulationdistanceandPVO2(r=0.619,P<0.001)insix-minutewalktest.Theregressionequationwassetup(VO2/kg=0.05D-6.331,P<0.001).PVO2>PVCO2,R<1werefound,whichsuggestedthat6MWTwasatestbelowanaerobicthreshold.ConclusionsTherewasacloselypositivelinearcorrelationbetweentheambulationdistanceandPVO2,whichissafety,convenientandvaluablefortheevaluationofcardiopulmonaryfunctionandthetreatmentofcardiopulmonaryrehabilitation.
简介:
简介:无
简介:AbstractObjective:Emetine, an isoquinoline alkaloid that is enriched at high concentrations in the lung, has shown potent in vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The aim of this study was to better understand the effectiveness of low-dose emetine for patients with coronavirus disease 2019 (COVID-19).Methods:In this real-world study, 63 patients with mild or common COVID-19 were recruited from Wuhan Fangcang Shelter Hospital and five COVID-19-designated hospitals in Anhui Province, China from February to March 2020. Thirty-nine patients from Wuhan Fangcang Shelter Hospital were assigned to a pragmatic randomized controlled clinical trial, and 24 patients from the 5 COVID-19-designated hospitals in Anhui Province underwent a real-world study. The medication course of emetine was less than 10 days. The main symptoms and adverse reactions of all patients were observed and recorded. The primary outcome measure was the time required for a negative SARS-CoV-2 RNA result or the negative result rate on day 10. Secondary outcomes included axillary temperature, transcutaneous oxygen saturation, and respiratory frequency recovery. The study was approved by the Ethics Committee of The First Affiliated Hospital of Anhui Medical University on February 20, 2019 (approval No. PJ2020-03-19) and was registered with the Chinese Clinical Trial Registry on February 20, 2019 (registration number: ChiCTR2000030022).Results:The oxygen saturation values were higher in the treatment group than in the control group on the first day after enrollment for patients treated at Fangcang Shelter Hospital. The axillary body temperature, respiratory rate, and oxygen saturation among patients in Fangcang Shelter Hospital were related to the time effect but not to the intervention measures. The respiratory rate and oxygen saturation of patients in the Anhui designated hospitals were related to the intervention measures but not to the time effect. The axillary body temperature of patients in Anhui designated hospitals was related to the time effect but not to the intervention measures.Conclusion:Our preliminary study shows that low-dose emetine combined with basic conventional antiviral drugs improves clinical symptoms in patients with mild and common COVID-19 without apparent adverse effects, suggesting that moderately increased doses of emetine may have good potential for treatment and prevention of COVID-19.
简介:
简介:AbstractBackground:Re-biopsy of metastasis in advanced breast cancer (ABC) has become an international convention to assist the diagnosis and evaluation of tumor heterogeneity. This study aimed to detect diagnostic diversity and inconsistencies among estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression levels between primary and metastatic lesions.Methods:We conducted a retrospective analysis of 1670 cases of ABC patients who had undergone at least one lesion re-biopsy from January 2010 to December 2018. The pathological diagnosis of biopsies, distribution of biopsy sites, and severe puncture complications at each site were collected. In addition, the inconsistency rates and related factors of ER, PR, and HER2 expression between primary and metastatic lesions were analyzed fully considering patients’ demographic profiles and disease characteristics.Results:In total, 1670 cases of breast cancer (BC) patients diagnosed by pathology underwent one to four biopsies of recurrences or metastases in different sites or at different stages during the rescue treatment, producing 2019 histopathological specimens which were analyzed in the study. Pathological diagnosis showed that eight patients had benign pathological diagnoses, 11 patients had second primary malignant tumors but without recurrences of breast cancer, and 17 patients had pathologically confirmed breast cancer recurrences combined with second primary cancer. In 1173 patients who presented ER, PR, and HER2 expressions in primary and metastatic lesions, the inconsistency rates of ER, PR, and HER2 were 17.5% (205/1173), 31.3% (367/1173), and 13.9% (163/1173), respectively. The multivariate analysis showed that the age at the onset of breast cancer or adjuvant endocrine therapy was an independent factor affecting changes in PR expression level. Except one liver puncture with local hemorrhage and two lung punctures with hemopneumothorax, no other severe puncture complications occurred in 1950 non-surgical rebiopsies.Conclusions:The pathological diagnosis of metastasis re-biopsy of ABC was diverse, and the ER, PR, and HER2 expression levels were inconsistent between primary and metastatic lesions. Therefore, more attention should be paid to perform biopsies of relapsed and metastatic breast cancers routinely in clinical practice.